These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7525156)

  • 1. Development of screening and confirmation tests for antibodies to hepatitis C virus.
    Couroucé AM; Janot C
    Curr Stud Hematol Blood Transfus; 1994; (61):36-48. PubMed ID: 7525156
    [No Abstract]   [Full Text] [Related]  

  • 2. Should the c100 antigen be removed from HCV antibody assays?
    Zaaijer HL; Cuypers HT; Reesink HW; Lelie PN
    Vox Sang; 1994; 66(2):150. PubMed ID: 7514326
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analytical study of the Abbott and Ortho tests for screening and confirmation of anti-HCV antibodies. Le groupe de Travail "Hépatites virales" de la Société Française de Transfusion Sanguine].
    Janot C; Couroucé AM; Boudart D; Cotte C; Elghouzzi MH; Jullien AM; Lemaire JM; Maisonneuve P; Maniez-Montreuil M; Mattlinger B
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):171-82. PubMed ID: 1384522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impacts of blood screening on the incidence of posttransfusion hepatitis C in Japan.
    Yoshizawa H; Watanabe J
    Curr Stud Hematol Blood Transfus; 1994; (61):182-94. PubMed ID: 7525155
    [No Abstract]   [Full Text] [Related]  

  • 5. [Screening tests for anti-HCV antibodies: comparative results].
    Couroucé AM
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):183-91. PubMed ID: 1384523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to hepatitis C virus in blood donors and polytransfused patients of Macau (southeast China).
    Martins IA; Ling RC; Fai EL; Chai H; do Rosário Vong MA; de Olim GA
    Vox Sang; 1993; 65(3):245-6. PubMed ID: 7504374
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C virus RNA positivity among RIBA-3 indeterminates.
    Jha J; Arankalle VA; Banerjee K
    Vox Sang; 1995; 69(2):145-6. PubMed ID: 8585200
    [No Abstract]   [Full Text] [Related]  

  • 8. Variation in antibody reactivity to the hepatitis C virus by comparative immunoscreening and enzyme immunoassay.
    Gish RG; Warmerdam MT; Zeldis JB; Keeffe EB; Nakazato P; Lim J; Cox K; Kuramoto IK; Fry KE; Yarbough PO
    Viral Immunol; 1993; 6(1):49-54. PubMed ID: 7682814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discovery of the NANB hepatitis virus by gene technology.
    Decker RH
    Beitr Infusionsther; 1992; 30():6-12. PubMed ID: 1284768
    [No Abstract]   [Full Text] [Related]  

  • 10. Significance of HCV RIBA-2 indeterminate results in high-risk individuals: assessment by a new third-generation RIBA assay and PCR.
    García-Samaniego J; Soriano V; Silva E; Enríquez A; Muñoz F; González-Lahoz J; Di Bisceglie A
    Vox Sang; 1994; 66(2):148-9. PubMed ID: 7514325
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-hepatitis C virus antibodies in monoclonal gammopathy: an appraisal using the second generation tests.
    Marson P; Vicarioto M; De Silvestro G; Tenderini ML; Nardo G; Ongaro G
    Haematologica; 1992; 77(2):188. PubMed ID: 1328000
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serological diagnosis of anti-HCV antibodies. Tests for screening and confirmation: analytical study. Le groupe "Hépatites virales" de la Société Française de Transfusion Sanguine].
    Maniez-Montreuil M
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):163-9. PubMed ID: 1329791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An easy dipstick assay for anti-core antibodies to screen blood donors for hepatitis C virus viremia.
    Mulyanto ; Suwignyo S; Tsauri S; Itoh K; Mizui M; Tsuda F; Okamoto H; Yoshizawa H; Mishiro S
    Vox Sang; 1996; 70(4):229-31. PubMed ID: 9123929
    [No Abstract]   [Full Text] [Related]  

  • 14. Are synthetic peptides sensitive enough for screening anti-hepatitis C virus at blood banks?
    León P; López JA; Elola C; Domingo CJ; Echevarría JM
    Vox Sang; 1994; 67(1):83-4. PubMed ID: 7526551
    [No Abstract]   [Full Text] [Related]  

  • 15. Asymptomatic anti-HCV seropositive subjects include patients with chronic active hepatitis and individuals with normal liver: can we distinguish them?
    Manzini P; Calvo PL; Abate ML; Cerchier A; Piantino P; Vallauri P; D'Antico S; Sympson B; Klarmann R; Schiffer M
    J Hepatol; 1994 Jul; 21(1):136-7. PubMed ID: 7525695
    [No Abstract]   [Full Text] [Related]  

  • 16. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
    Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
    Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved detection of antibodies to hepatitis C virus by use of a new recombinant immunoblot assay.
    Joller-Jemelka HI; Wicki AN; Opitz R
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):398-400. PubMed ID: 7689054
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation between ELISA and recombinant immunoblot assay in serum samples positive for anti-HCV.
    Lin HH; Hsu HY; Chang MH; Wang JT; Chen PJ; Chen DS
    J Formos Med Assoc; 1992 Jul; 91(7):729-30. PubMed ID: 1360305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgM anti-C100-3 antibodies in hepatitis C virus infection.
    Sansonno D; Gatti P
    Int J Clin Lab Res; 1992; 21(3):267-8. PubMed ID: 1317226
    [No Abstract]   [Full Text] [Related]  

  • 20. [Reactivity of hepatitis C virus (HCV) antibody among blood donors in Hungary].
    Héjjas M; Medgyesi G; Hajnal A
    Orv Hetil; 1992 Jul; 133 Suppl 1():21-4. PubMed ID: 1321394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.